C41 - Neuro-oncology in 2019: Navigating Current Trends
| Event Time: | Sunday May 5, 2019 7:00 am to 9:00 am |
| Topic(s): | Neuro-oncology |
| Director(s): | Maciej Mrugala MD, PhD, MPH, FAAN |
| Description: | This program will aim to teach residents, fellows, general neurologists, and junior neuro-oncologists about the most recent developments in the field of neuro-oncology. The first talk will cover new experimental therapies showing promise. Patients are frequently asking about these therapies, and critical overview of the data for the practicing clinician will be provided. The second talk will address molecular diagnostics in primary brain tumors. This is an area of active research and many of the molecular markers recently discovered have clinical utility. Practical information about ordering different molecular panels and how to interpret them will be provided. In the third talk we will cover novel surgical techniques being already used or in stages of advanced development, in therapy for primary and metastatic brain tumors. We will emphasize information important for clinicians when advising patients about pros and cons of each therapeutic approach. |
| Completion Message: | Participants should be able to identify novel developments in the field of neuro-oncology with emphasis on molecular testing, and new emerging therapies. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
| Start/End Time | Title | Faculty |
|---|---|---|
| 7:05 AM - 7:05 AM | Introduction | Maciej M. Mrugala MD, PhD, MPH, FAAN |
| 7:05 AM - 7:45 AM | Deciphering Molecular Testing in Neuro-oncology | Seema Nagpal MD |
| 7:45 AM - 8:20 AM | Medical Therapies in Neuro-oncology: What is New? | Maciej M. Mrugala MD, PhD, MPH, FAAN |
| 8:20 AM - 9:00 AM | Advances in Neurosurgical Treatment of Brain Tumors | Daniel P. Cahill MD, PhD |
| Speaker | Disclosure |
|---|---|
| Daniel P. Cahill, MD, PhD | Dr. Cahill has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lilly and Merck. |
| Maciej M. Mrugala, MD, PhD, MPH, FAAN | Dr. Mrugala has received research support from Arbor Pharmaceuticals. |
| Seema Nagpal, MD | Dr. Nagpal has nothing to disclose. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C5 -
What Do I Do Now?: Neurologic Consultations in Cancer Patients I
Jaishri Blakeley MD |
| 9:30 AM-11:30 AM |
|
C17 -
What Do I Do Now?: Neurologic Consultations in Cancer Patients II
Patrick Wen MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
| 9:15 AM-12:00 PM |
|
Presidential Plenary Session
Natalia Rost MD, MPH, FAAN, FAHA |
| 11:30 AM-6:30 PM |
|
P1 -
Poster Session 1
|
| 3:30 PM-5:30 PM |
|
C69 -
The Palliative Care Guide in Neurology: Best Practice in Communication, Advance Care Planning, and End-of-life Care of Patients with Brain Tumors and Other Life-limiting Neurological Disorders
Tobias Walbert MD, PhD |
| 4:45 PM-5:30 PM |
|
Neuro-oncology Section Guided Poster Tour
|
| 7:00 AM-9:00 AM |
|---|
|
C81 -
Core Principles of Brain Tumors
Nimish Mohile MD, FAAN |
| 11:30 AM-6:30 PM |
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
S14 -
Translational and Clinical Advances in Neuro-oncology
|
| 3:30 PM-5:30 PM |
|
C110 -
Adult and Pediatric Neuro-Oncology for the Neurohospitalist
Na Tosha Gatson MD, PhD |
| 9:15 AM-11:30 AM |
|---|
|
Clinical Trials Plenary Session
Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 3:30 PM-5:30 PM |
|
S30 -
Brain Cancer: From Epidemiology to Quality of Life
|
| 1:00 PM-3:00 PM |
|---|
|
C178 -
Therapy in Neurology I: Neurological Infectious Diseases and Neuro-oncology
Madhu Soni MD, FAAN |
| 2:00 PM-2:30 PM |
|---|
|
Choosing a Career in Neuro-oncology
Sylvia Kurz MD, PhD |